Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is N/A as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly gross margin; no daily interpolation. Q1 FY2027 (2026-07-31): -1580.38%.
GROSS MARGIN
N/A
GROSS MARGIN AVG TTM
-894.00%
GROSS MARGIN AVG 3Y
-401.76%
GROSS MARGIN AVG 5Y
-51.29%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
HeartSciences Inc.
Market Cap
$8.10M
Gross Margin
N/A
TTM Avg
-894.00%
3Y Avg
-401.76%
5Y Avg
-51.29%
Market Cap
$8.19M
Gross Margin
0.00%
TTM Avg
-261.58%
3Y Avg
-106.09%
5Y Avg
-70.73%
Market Cap
$7.98M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.42M
Gross Margin
18.37%
TTM Avg
19.16%
3Y Avg
20.84%
5Y Avg
23.00%
Market Cap
$7.75M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.47M
Gross Margin
-41.30%
TTM Avg
-15.77%
3Y Avg
-3.50%
5Y Avg
-3.50%
Market Cap
$7.62M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.31M
Gross Margin
14.92%
TTM Avg
28.44%
3Y Avg
28.69%
5Y Avg
27.44%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartSciences Inc. (HSCS) | $8.10M | N/A | -894.00% | -401.76% | -51.29% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.19M | 0.00% | -261.58% | -106.09% | -70.73% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| GT Biopharma, Inc. (GTBP)vs › | $8.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.42M | 18.37% | 19.16% | 20.84% | 23.00% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.47M | -41.30% | -15.77% | -3.50% | -3.50% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 14.92% | 28.44% | 28.69% | 27.44% |
| Longeveron Inc. (LGVN)vs › | $7.27M | 69.76% | 72.87% | 54.39% | 49.20% |
Gross Margin
N/A
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-07-31 | -1580.38% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | -1282.51% |
| 2025-07-31 | -1607.11% |
| 2025-04-30 | -661.86% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 43.69% |
| 2023-10-31 | -134.77% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2023-01-31 | -291.03% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | -164.00% |
| 2022-04-30 | -87.42% |
| 2022-01-31 | -168.25% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | -70.08% |
| 2021-04-30 | 58.39% |
